AVANTOR INC
AVTRNYSETrading Snapshot
- Day Range
- $16.17 โ $17.22
- 52-Week Range
- $7.27 โ $17.45
- Volume (shares)
- 29,719,213
- Avg Volume (shares)
- โ
- Shares Outstanding
- 676.4M
- Next Earnings
- 2026-10-28
Fundamentals Snapshot
- Annual Revenue
- $6.55B
- Last Q Revenue
- $1.69B
- P/E Ratio
- โ
- P/S Ratio
- 1.8x
- EPS (TTM)
- $-0.85
- Dividend Yield
- โ
- Dilution (1yr)
- โ0.5%
AVANTOR INC
AVTRAbout AVANTOR INC
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Analyst Ratings
โLatest News & Updates

Avantor, Inc. (AVTR) Q3 2026 Earnings Call Transcript
Avantor, Inc. ( AVTR ) Q3 2026 Earnings Call October 28, 2026 8:00 AM EDT Company Participants Chris Fidyk - Vice President of Investor Relations Emmanuel Ligner - President, CEO & Director Todd Garner - Executive VP & C

What Avantor (AVTR) Said on Its Q3 Earnings Call
Avantor NYSE: AVTR reported a return to organic revenue growth in the third quarter of 2026, led by accelerating performance in its VWR Distribution & Services segment and a return to growth in its Bioscience & Medtech P

Avantor, Inc. (AVTR) Surpasses Q3 Earnings and Revenue Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.22 per share a year ago.

Avantorยฎ Reports Third Quarter 2026 Results
Net sales of $1,698.3 million; increase of 4.6%; organic increase of 5.2% Diluted GAAP EPS of $0.30; adjusted EPS of $0.22 Raised FY 2026 organic revenue growth, adjusted EPS and free cash flow guidance RADNOR, Pa., Oct.

Avantor appoints new Chief Information Officer
RADNOR, Pa., Oct. 26, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, welcomes Mi

Longleaf Partners Fund Q3 2026 Portfolio Review
The market is regaining confidence in Avantor's ability to grow organically and in Emmanuel Ligner's turnaround plan. Biopharma company Regeneron reported a solid set of results, with key drug Dupixent continuing to outp